Estrogen Receptor Positive Tumor Recruiting Phase 2 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0050145 (Estrogen Receptor Positive Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02603679Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesTreatment